MDCO - The Medicines Company - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $9.61. This is a potential upside of $9.61 (0%) from yesterday's end of day stock price of $0.

The Medicines Company's activity chart (see below) currently has 88 price targets and 73 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.4% with an average time for these price targets to be met of 358 days.

Most recent stock forecast was given by GBOLA AMUSA from CHARDAN CAPITAL on 26-Nov-2019. First documented stock forecast 06-Jun-2013.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Mar-2016

$85

$0.1 (0.12%)

$90

6 years 4 months 9 days ago
(26-Nov-2019)

1/5 (20%)

$1.12 (1.34%)

1338

Buy Since 28-Mar-2019

$85

$0.1 (0.12%)

$100

6 years 4 months 10 days ago
(25-Nov-2019)

1/5 (20%)

$1.25 (1.49%)

243

Buy Since 30-Nov-2017

$68

$-16.9 (-19.91%)

$68

6 years 4 months 10 days ago
(25-Nov-2019)

4/6 (66.67%)

$-15.75 (-18.81%)

235

Hold Since 20-Nov-2019

$59

$-25.9 (-30.51%)

$55

6 years 4 months 15 days ago
(20-Nov-2019)

8/9 (88.89%)

$-11.59 (-16.42%)

148

Buy Since 19-Apr-2017

$60

$-24.9 (-29.33%)

$55

6 years 5 months 4 days ago
(31-Oct-2019)

5/5 (100%)

$7.51 (14.31%)

205

Show more analysts

Please expand the browser size to see the chart

What is MDCO (The Medicines Company) average time for price targets to be met?

On average it took 358 days on average for the stock forecasts to be realized with a an average price target met ratio 85.4

Which analyst has the current highest performing score on MDCO (The Medicines Company) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on MDCO (The Medicines Company)?

Yasmeen Rahimi works at PIPER SANDLER and has 7 price targets and 9 ratings on MDCO

Which analyst is the currently most bullish on MDCO (The Medicines Company)?

Madhu Kumar with highest potential upside - $0.1

Which analyst is the currently most reserved on MDCO (The Medicines Company)?

David Amsellem with lowest potential downside - -$53.9

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?